A detailed history of Watts Gwilliam & Co., LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Watts Gwilliam & Co., LLC holds 1,083 shares of LLY stock, worth $1.11 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,083
Previous 1,083 -0.0%
Holding current value
$1.11 Million
Previous $844,000 2.13%
% of portfolio
0.12%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Sep 19, 2025

SELL
$713.71 - $898.95 $1.87 Million - $2.36 Million
-2,625 Reduced 70.79%
1,083 $844,000
Q1 2025

May 13, 2025

BUY
$725.72 - $929.72 $1.47 Million - $1.88 Million
2,020 Added 119.67%
3,708 $3.06 Million
Q4 2024

Jan 08, 2025

BUY
$727.2 - $932.06 $69,811 - $89,477
96 Added 6.03%
1,688 $1.31 Billion
Q3 2024

Oct 09, 2024

BUY
$772.14 - $960.02 $74,897 - $93,121
97 Added 6.49%
1,592 $1.45 Billion
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $885,339 - $1.18 Million
1,495 New
1,495 $1.14 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Watts Gwilliam & Co., LLC Portfolio

Follow Watts Gwilliam & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Watts Gwilliam & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Watts Gwilliam & Co., LLC with notifications on news.